Keros Therapeutics, Inc. · NASDAQ:KROS

ADAR1 Capital Management, LLC reported a 13.27% stake in Keros Therapeutics, Inc. (Schedule 13D/A)

Event Aug 21, 2025 · Filed Aug 21, 2025

ADAR1 Capital Management, LLC reported a 13.27% stake in Keros Therapeutics, Inc., 5,389,264 shares, with active intent on Aug 21, 2025. Filed Aug 21, 2025 (Schedule 13D/A).

Stake
13.27%
Shares
5,389,264
Intent
Active
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC13.27%5,389,264
ADAR1 Capital Management GP, LLC11.44%4,645,906
Daniel Schneeberger13.27%5,389,264

Source

View original at SEC

Related